Treatment patterns adverse events healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States

摘要

There are limited data on treatment patterns, adverse events (AEs), and economic burden in younger, commercially insured patients treated for mantle cell lymphoma (MCL).